Direct Peritoneal Resuscitation Effects in the Damage Control Patient
The purpose of this study is to find if direct peritoneal resuscitation helps blood flow through important organs in a person's body after they have had a traumatic injury with massive blood loss. Sometimes after severe injuries requiring operation, surgeons cannot close the muscles and skin of a patient's belly, because of swelling. This study will also try to find if direct peritoneal resuscitation decreases tissue swelling and allows for quicker closure of of a patient's belly.
Procedure: Standard surgical methods
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Direct Peritoneal Resuscitation Effects in the Damage Control Patient|
- Morbidity [ Time Frame: 1 Month ] [ Designated as safety issue: No ]Evaluate the effect of adjunctive DPR on visceral (liver) organ and systemic perfusion and cellular necrosis in patients in hemorrhagic shock.
|Study Start Date:||January 2012|
|Estimated Study Completion Date:||June 2015|
|Estimated Primary Completion Date:||January 2015 (Final data collection date for primary outcome measure)|
Galactose dripped into the abdomen after surgery
Placebo Comparator: Standard resuscitation
Standard surgical methods of controlling bleeding
|Procedure: Standard surgical methods|
Standard methods of controlling bleeding and increasing blood flow to vital organs will be used. These methods include giving blood and fluids and surgically repairing the vessels that are causing the bleeding which are standard ways physicians treat injuries with massive blood loss. A drain (a small plastic tube) will be placed inside the belly.
Subjects will randomly (like flipping a coin) be placed into a group of patients who either get a sugar solution dripped into the belly after surgery or do not get this treatment. The drain will be used to drip a high glucose solution into the abdomen in patients be part of that group. The fluid will continue to be dripped into the belly until it is possible to close the skin and underlying layers.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01771055
|United States, Kentucky|
|University of Louisville Hospital||Recruiting|
|Louisville, Kentucky, United States, 40202|
|Contact: Jason Smith, MD 502-852-1895 firstname.lastname@example.org|
|Principal Investigator: Jason Smith, MD|
|Principal Investigator:||Jason Smith, MD||University of Louisville|